サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1513897

遠隔患者モニタリングシステムの世界市場

Remote Patient Monitoring Systems

出版日
ページ情報
英文 442 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
遠隔患者モニタリングシステムの世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 442 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

遠隔患者モニタリングシステムの世界市場は2030年までに91億米ドルに達する見込み

2023年に26億米ドルと推定される遠隔患者モニタリングシステムの世界市場は、2023年から2030年にかけてCAGR 19.6%で成長し、2030年には91億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである特殊モニタは、CAGR 18.9%を記録し、分析期間終了時には72億米ドルに達すると予測されます。バイタルサインモニター分野の成長率は、分析期間中CAGR 22.9%と推定されます。

米国市場は推定7億2,060万米ドル、中国はCAGR18.6％で成長予測

米国の遠隔患者モニタリングシステム市場は、2023年に7億2,060万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに14億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは18.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ17.0％と16.7％と予測されています。欧州では、ドイツがCAGR約13.8%で成長すると予測されています。

世界の遠隔患者モニタリングシステム市場- 主要動向と促進要因まとめ

遠隔患者モニタリング（RPM）システムは、糖尿病や高血圧などの慢性疾患の管理に不可欠なサービスを提供し、ケア提供を強化するヘルスケアにおいて、ますます重要性を増しています。血圧計、血糖値計、スマートウォッチのような先進的なウェアラブルなどの治療機器を利用するRPMシステムは、健康データの継続的な収集を可能にし、医療提供者はこれを利用して患者をモニタリングし、それに応じて治療計画を調整します。調査では、入院期間の短縮や、治療のタイムリーな調整による慢性疾患の管理改善など、RPMの利点が強調されています。特にパンデミック（世界的大流行）の際には、RPMが遠隔地から患者を監視し、病院の負担を軽減する上で極めて重要であることが証明されました。また、病院レベルの治療を在宅の患者に提供することで、緊急時の受診や入院を減らす在宅医療プログラムでも効果を発揮しています。

RPMの規制状況は急速に進化しており、特にCOVID-19パンデミックの際に浮き彫りになったニーズが拍車をかけています。メディケア・メディケイド・サービスセンター（CMS）のような機関が、RPMの利用を拡大するための新しい政策や免除措置を導入したことで、これらのシステムはより利用しやすくなり、さまざまなヘルスケア環境に適用できるようになった。将来を展望すると、先端技術の統合とRPMの利点に対する認識の高まりは、有望な未来を指し示しています。このことは、複雑な症例を遠隔で管理するために医療システムがRPMを採用するケースが増えていることからも明らかであり、その結果、物理的なヘルスケア施設への負担が軽減されます。技術の継続的な進歩と追加資金により、RPM装置の機能と効率は向上しており、遠隔モニタリングが現代のヘルスケア提供の基礎的側面であり続けることを確実にしています。

RPM技術の成長を促す要因はいくつかあります。データ分析とAI統合の強化により、患者モニタリングの精度が向上し、予測的なヘルスケア介入が可能になります。5Gなどの接続ソリューションの改善により、RPM機器から医療提供者への信頼性の高いデータ伝送が保証されます。また、消費者の健康意識も大幅に高まっており、リアルタイムの健康指標フィードバックを提供する健康モニタリング機器への需要が高まっています。ウェアラブル技術の人気は継続的な健康追跡を正常化し、RPMの受容をさらに後押ししています。メディケアやメディケイドを含む保険業者による支持的な規制枠組みや償還政策の拡大により、RPMサービスはより利用しやすく手頃な価格になっています。さらに、遠隔診療に対する患者の要望や、業務効率化のためにRPMを採用する医療提供者の動きは、より統合された、テクノロジー主導の、患者中心の医療ソリューションへのシフトを浮き彫りにしています。これらの要因が総合的にRPMシステムの導入と有効性を高め、ヘルスケア管理手法の継続的な変革を反映しています。

調査対象企業の例（全162件）

  • Biotronik SE & Co. KG
  • F. Hoffmann-La Roche AG
  • Intel Corporation
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic of Canada Ltd.
  • Philips Healthcare
  • Robert Bosch GmbH
  • Welch Allyn, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP-7076

Global Remote Patient Monitoring Systems Market to Reach US$9.1 Billion by 2030

The global market for Remote Patient Monitoring Systems estimated at US$2.6 Billion in the year 2023, is expected to reach US$9.1 Billion by 2030, growing at a CAGR of 19.6% over the analysis period 2023-2030. Special Monitors, one of the segments analyzed in the report, is expected to record a 18.9% CAGR and reach US$7.2 Billion by the end of the analysis period. Growth in the Vital Sign Monitors segment is estimated at 22.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$720.6 Million While China is Forecast to Grow at 18.6% CAGR

The Remote Patient Monitoring Systems market in the U.S. is estimated at US$720.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 18.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.0% and 16.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.8% CAGR.

Global Remote Patient Monitoring Systems Market - Key Trends and Drivers Summarized

Remote Patient Monitoring (RPM) systems are increasingly critical in healthcare, providing vital services for the management of chronic diseases like diabetes and hypertension and enhancing care delivery. Utilizing devices such as blood pressure monitors, blood glucose meters, and advanced wearables like smartwatches, RPM systems allow continuous collection of health data, which healthcare providers use to monitor patients and adjust treatment plans accordingly. Research has highlighted the benefits of RPM, including reducing hospital stay lengths and improving the management of chronic diseases by facilitating timely adjustments in treatment. Especially evident during the pandemic, RPM proved crucial for monitoring patients remotely, alleviating hospital burdens, and has been effective in hospital-at-home programs, which deliver hospital-level care to patients at home, thereby reducing emergency visits and hospitalizations.

The regulatory landscape for RPM has evolved rapidly, particularly spurred by the needs highlighted during the COVID-19 pandemic. Changes by entities like the Centers for Medicare and Medicaid Services (CMS), which introduced new policies and waivers to broaden RPM usage, have made these systems more accessible and applicable across various healthcare settings. Looking forward, the integration of advanced technologies and a growing recognition of the benefits of RPM point to a promising future. This is evidenced by the increasing adoption of RPM by health systems to manage complex cases remotely, thus reducing pressure on physical healthcare facilities. Continued advancements in technology and additional funding are enhancing the capabilities and efficiency of RPM devices, ensuring that remote monitoring remains a foundational aspect of modern healthcare delivery.

Several factors are driving the growth of RPM technology. Enhanced data analytics and AI integration improve patient monitoring accuracy, enabling predictive healthcare interventions. Improvements in connectivity solutions, such as 5G, ensure reliable data transmission from RPM devices to healthcare providers. There's also a significant increase in consumer health awareness, which has boosted demand for health monitoring devices providing real-time health metrics feedback. The popularity of wearable technologies has normalized continuous health tracking, further aiding RPM acceptance. Supportive regulatory frameworks and expanded reimbursement policies by insurance providers, including Medicare and Medicaid, are making RPM services more accessible and affordable. Additionally, patient demand for remote care options and healthcare providers' adoption of RPM for operational efficiency highlight the shift towards more integrated, technology-driven, and patient-centered healthcare solutions. These factors collectively enhance the adoption and effectiveness of RPM systems, reflecting an ongoing transformation in healthcare management practices.

Select Competitors (Total 162 Featured) -

  • Biotronik SE & Co. KG
  • F. Hoffmann-La Roche AG
  • Intel Corporation
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic of Canada Ltd.
  • Philips Healthcare
  • Robert Bosch GmbH
  • Welch Allyn, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Remote Patient Monitoring Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Telehealth and Remote Healthcare Solutions
    • Growth of the Aging Population and Chronic Disease Management
    • Advancements in Remote Monitoring Technologies and Wearable Devices
    • Rising Adoption of Remote Patient Monitoring in Post-Acute Care
    • Impact of COVID-19 Pandemic on Healthcare Delivery and Remote Monitoring
    • Government Regulations and Standards for Telehealth and Remote Monitoring
    • Expansion of Remote Monitoring Applications in Home Healthcare
    • Development of Integrated and Real-Time Health Monitoring Platforms
    • Role of Remote Monitoring in Enhancing Patient Outcomes and Healthcare Efficiency
    • Market Penetration of Remote Monitoring in Rural and Underserved Areas
    • Influence of Technological Innovations on Data Accuracy and Connectivity
    • Growth of Remote Monitoring Applications in Chronic Disease Management
    • Challenges Related to Data Security and Patient Privacy Concerns
    • Emerging Markets and Growth Opportunities in Developing Regions
    • Future Trends and Innovations in Remote Patient Monitoring Systems and Healthcare Delivery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Vital Sign Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Vital Sign Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Vital Sign Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Special Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Special Monitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Special Monitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Sleep Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Sleep Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Sleep Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Hospital based Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Hospital based Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Hospital based Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Ambulatory Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Ambulatory Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Ambulatory Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Hypertension by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 34: World Remote Patient Monitoring Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Remote Patient Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Remote Patient Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • JAPAN
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • CHINA
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • EUROPE
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Remote Patient Monitoring Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Remote Patient Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • GERMANY
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Remote Patient Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Remote Patient Monitoring Systems by Product Type - Special Monitors and Vital Sign Monitors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Remote Patient Monitoring Systems by Product Type - Percentage Breakdown of Value Sales for Special Monitors and Vital Sign Monitors for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Remote Patient Monitoring Systems by Application - Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Remote Patient Monitoring Systems by Application - Percentage Breakdown of Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Remote Patient Monitoring Systems by End-Use - Hospital based Patients, Ambulatory Patients and Home Healthcare Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Remote Patient Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Hospital based Patients, Ambulatory Patients and Home Healthcare for the Years 2014, 2024 & 2030

IV. COMPETITION